AllianceLifeSciences retweeted
As countries around the world tackle the challenges of #healthcare, news like this is welcomed. Read how New Zealand is taking steps to improve access to rare disease treatments.
globalgenes.org/raredaily/ne…
AllianceLifeSciences retweeted
Roche’s Tecentriq in combination with Avastin gets breakthrough therapy designation by FDA. #livercancer
roche.com/media/releases/med…
AllianceLifeSciences retweeted
FDA awards orphan designation to Asceneuron’s drug for progressive supranuclear palsy. #RareDisease
asceneuron.com/news/asn12029…
AllianceLifeSciences retweeted
We strive to go above and beyond with everything we do. The Above & Beyond Award lets PEP employees recognize each other for going beyond the call of duty in our work. We carry the award as a badge of honor and strive to earn it!
the-pep.com/#careers
AllianceLifeSciences retweeted
Keytruda gets approval from FDA to treat patients with primary mediastinal large B-cell #lymphoma (PMBCL).
mrknewsroom.com/news-release…
AllianceLifeSciences retweeted
Alimta in combination with Keytruda and Carboplatin gets approved by FDA for the first-line treatment for metastatic nonsquamous #NSCLC
investor.lilly.com/news-rele…
AllianceLifeSciences retweeted
PEP has a new project manager. Kelly Carpenter comes to PEP with experience effectively meeting project deliverables and deadlines. Learn more about the latest addition to the PEP team.
the-pep.com/kelly-carpenter-…
AllianceLifeSciences retweeted
Cloudy skies couldn't dampen the PEP spirit at Ryan's Run on Saturday! All proceeds support research for and families affected by malignant infantile osteopetrosis (MIOP). Learn more at: curemiop.org/
AllianceLifeSciences retweeted
FDA approved AstraZeneca's Lokelma for the treatment of adults with hyperkalemia.
astrazeneca.com/media-centre…
AllianceLifeSciences retweeted
.@ModelN is thrilled to welcome Jason Blessing as our new CEO @jason_blessing @zrinat buff.ly/2IonoFQ
AllianceLifeSciences retweeted
#ISPORnews: ISPOR launches new Center for Health Technology Assessment website. HTAcenter.org offers comprehensive repository of resources and tools. #HTA #HEOR #healthtechnologyassessment ow.ly/GWFq30jWOMd
AllianceLifeSciences retweeted
PEP and @peptrials were at the @orphanconf last month -- along with a lot of zebras #wodcusa
the-pep.com/insights-2018-wo…
AllianceLifeSciences retweeted
James Watson & Francis Crick published their breakthrough paper on how genetic material passes from generation to generation #OnThisDay in 1953, via @NobelPrize. Read more about the double helical structure of DNA here: https://nitter.cf/t.co/emjVMGmGFp
AllianceLifeSciences retweeted
Poor rebate program design and higher complexity could be costing you millions. Learn how to reduce overpayments and increase revenue through better rebate management. buff.ly/2JoqLcK
AllianceLifeSciences retweeted
PHARMA PRICING & PROFIT OPTIMISATION BENCHMARK MEETING going on. Alan Crowther from Alliance Life Sciences sharing latest insights on operational pricing approaches, analytical uses, tools and trends/techniques being applied in the market ! #analytics #l…lnkd.in/eEsbTnC
AllianceLifeSciences retweeted
GE to sell part of health-care division to Veritas Capital for $1.05 billion wsj.com/articles/ge-to-sell-… via @WSJ
AllianceLifeSciences retweeted
#ISPORnews: ISPOR announces new #HEOR #training programs open for registration. #HTA #PROs #healtheconomics #outcomesresearch ow.ly/M79X30j1EIY
AllianceLifeSciences retweeted
#MODN remains a strong valuation proposition for investors, says Dougherty & Co., following strong #analystday showing. The research group reiterated previous #buy rating and raised price targed to $22 from $20
AllianceLifeSciences retweeted
World Pharma Pricing And Market Access Congress 2018,@TheBDC,On 20th - 21st March,2018 at 9:00 am to 5:00 pm,go.evvnt.com/143431-0, #ppma – at London, England
AllianceLifeSciences retweeted
Thanks to all who participated in Rainmaker 2018! Here's a video recap of the highlights of the revenue management event of the year. buff.ly/2FhLUo5 #MNRM18



















